| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A structure-specific small molecule inhibits a miRNA-200 family member precursor and reverses a type 2 diabetes phenotype
|
Haniff, Hafeez S.
|
|
|
29 |
2 |
p. 300-311.e10
|
artikel
|
| 2 |
Chemically modified guide RNAs enhance CRISPR-Cas13 knockdown in human cells
|
Méndez-Mancilla, Alejandro
|
|
|
29 |
2 |
p. 321-327.e4
|
artikel
|
| 3 |
Chemogenomics identifies acetyl-coenzyme A synthetase as a target for malaria treatment and prevention
|
Summers, Robert L.
|
|
|
29 |
2 |
p. 191-201.e8
|
artikel
|
| 4 |
Cytidine acetylation yields a hypoinflammatory synthetic messenger RNA
|
Nance, Kellie D.
|
|
|
29 |
2 |
p. 312-320.e7
|
artikel
|
| 5 |
Development of an intracellular quantitative assay to measure compound binding kinetics
|
Lay, Charles S.
|
|
|
29 |
2 |
p. 287-299.e8
|
artikel
|
| 6 |
DogCatcher allows loop-friendly protein-protein ligation
|
Keeble, Anthony H.
|
|
|
29 |
2 |
p. 339-350.e10
|
artikel
|
| 7 |
Engineered protein-small molecule conjugates empower selective enzyme inhibition
|
Lewis, Andrew K.
|
|
|
29 |
2 |
p. 328-338.e4
|
artikel
|
| 8 |
Generation of an anticoagulant aptamer that targets factor V/Va and disrupts the FVa-membrane interaction in normal and COVID-19 patient samples
|
Soule, Erin E.
|
|
|
29 |
2 |
p. 215-225.e5
|
artikel
|
| 9 |
Identification of a PCSK9-LDLR disruptor peptide with in vivo function
|
Brousseau, Margaret E.
|
|
|
29 |
2 |
p. 249-258.e5
|
artikel
|
| 10 |
Increased energy demand from anabolic-catabolic processes drives β-lactam antibiotic lethality
|
Lobritz, Michael A.
|
|
|
29 |
2 |
p. 276-286.e4
|
artikel
|
| 11 |
Ligand-directed bias of G protein signaling at the dopamine D2 receptor
|
Von Moo, Ee
|
|
|
29 |
2 |
p. 226-238.e4
|
artikel
|
| 12 |
Making the cut with protease engineering
|
Dyer, Rebekah P.
|
|
|
29 |
2 |
p. 177-190
|
artikel
|
| 13 |
No acetyl-CoA keeps Plasmodium at bay
|
Jeffers, Victoria
|
|
|
29 |
2 |
p. 174-176
|
artikel
|
| 14 |
Splicing modulators elicit global translational repression by condensate-prone proteins translated from introns
|
Chhipi-Shrestha, Jagat K.
|
|
|
29 |
2 |
p. 259-275.e10
|
artikel
|
| 15 |
The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors
|
Palve, Vinayak
|
|
|
29 |
2 |
p. 202-214.e7
|
artikel
|
| 16 |
TREM2 is thyroid hormone regulated making the TREM2 pathway druggable with ligands for thyroid hormone receptor
|
Ferrara, Skylar J.
|
|
|
29 |
2 |
p. 239-248.e4
|
artikel
|
| 17 |
Two birds, one stone: Non-canonical therapeutic effects of the PARP inhibitor Talazoparib
|
Challa, Sridevi
|
|
|
29 |
2 |
p. 171-173
|
artikel
|
Tijdschrift beschrijving